London · Delayed Price · Currency is GBP · Price in GBX GSK plc Statistics
Total Valuation
GSK plc has a market cap or net worth of GBP 70.63 billion. The enterprise value is 84.68 billion.
| Market Cap | 70.63B |
| Enterprise Value | 84.68B |
Important Dates
The last earnings date was Wednesday, October 29, 2025.
| Earnings Date | Oct 29, 2025 |
| Ex-Dividend Date | Nov 13, 2025 |
Share Statistics
GSK plc has 4.02 billion shares outstanding. The number of shares has increased by 0.08% in one year.
| Current Share Class | 4.02B |
| Shares Outstanding | 4.02B |
| Shares Change (YoY) | +0.08% |
| Shares Change (QoQ) | -0.19% |
| Owned by Insiders (%) | 0.11% |
| Owned by Institutions (%) | 90.31% |
| Float | 3.89B |
Valuation Ratios
The trailing PE ratio is 13.22 and the forward PE ratio is 9.86. GSK plc's PEG ratio is 1.31.
| PE Ratio | 13.22 |
| Forward PE | 9.86 |
| PS Ratio | 2.20 |
| PB Ratio | 4.48 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 10.91 |
| P/OCF Ratio | 9.06 |
| PEG Ratio | 1.31 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.70, with an EV/FCF ratio of 13.08.
| EV / Earnings | 15.41 |
| EV / Sales | 2.63 |
| EV / EBITDA | 8.70 |
| EV / EBIT | 12.43 |
| EV / FCF | 13.08 |
Financial Position
The company has a current ratio of 0.84, with a Debt / Equity ratio of 1.13.
| Current Ratio | 0.84 |
| Quick Ratio | 0.54 |
| Debt / Equity | 1.13 |
| Debt / EBITDA | 1.82 |
| Debt / FCF | 2.74 |
| Interest Coverage | 10.96 |
Financial Efficiency
Return on equity (ROE) is 41.52% and return on invested capital (ROIC) is 13.51%.
| Return on Equity (ROE) | 41.52% |
| Return on Assets (ROA) | 7.13% |
| Return on Invested Capital (ROIC) | 13.51% |
| Return on Capital Employed (ROCE) | 17.02% |
| Revenue Per Employee | 468,694 |
| Profits Per Employee | 80,054 |
| Employee Count | 68,629 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 1.47 |
Taxes
In the past 12 months, GSK plc has paid 951.00 million in taxes.
| Income Tax | 951.00M |
| Effective Tax Rate | 13.56% |
Stock Price Statistics
The stock price has increased by +26.07% in the last 52 weeks. The beta is 0.29, so GSK plc's price volatility has been lower than the market average.
| Beta (5Y) | 0.29 |
| 52-Week Price Change | +26.07% |
| 50-Day Moving Average | 1,572.78 |
| 200-Day Moving Average | 1,466.24 |
| Relative Strength Index (RSI) | 74.15 |
| Average Volume (20 Days) | 7,752,783 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, GSK plc had revenue of GBP 32.17 billion and earned 5.49 billion in profits. Earnings per share was 1.33.
| Revenue | 32.17B |
| Gross Profit | 23.30B |
| Operating Income | 6.81B |
| Pretax Income | 7.01B |
| Net Income | 5.49B |
| EBITDA | 9.52B |
| EBIT | 6.81B |
| Earnings Per Share (EPS) | 1.33 |
Balance Sheet
The company has 3.31 billion in cash and 17.75 billion in debt, giving a net cash position of -14.44 billion or -3.59 per share.
| Cash & Cash Equivalents | 3.31B |
| Total Debt | 17.75B |
| Net Cash | -14.44B |
| Net Cash Per Share | -3.59 |
| Equity (Book Value) | 15.75B |
| Book Value Per Share | 4.01 |
| Working Capital | -3.49B |
Cash Flow
In the last 12 months, operating cash flow was 7.79 billion and capital expenditures -1.32 billion, giving a free cash flow of 6.47 billion.
| Operating Cash Flow | 7.79B |
| Capital Expenditures | -1.32B |
| Free Cash Flow | 6.47B |
| FCF Per Share | 1.61 |
Margins
Gross margin is 72.43%, with operating and profit margins of 21.17% and 17.08%.
| Gross Margin | 72.43% |
| Operating Margin | 21.17% |
| Pretax Margin | 21.81% |
| Profit Margin | 17.08% |
| EBITDA Margin | 29.59% |
| EBIT Margin | 21.17% |
| FCF Margin | 20.12% |
Dividends & Yields
This stock pays an annual dividend of 0.61, which amounts to a dividend yield of 3.47%.
| Dividend Per Share | 0.61 |
| Dividend Yield | 3.47% |
| Dividend Growth (YoY) | 4.92% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 46.05% |
| Buyback Yield | -0.08% |
| Shareholder Yield | 3.35% |
| Earnings Yield | 7.78% |
| FCF Yield | 9.16% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 19, 2022. It was a reverse split with a ratio of 0.8.
| Last Split Date | Jul 19, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.8 |
Scores
GSK plc has an Altman Z-Score of 1.81 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.81 |
| Piotroski F-Score | 7 |